A Multicenter, Adaptive, Randomised Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults - Version for Eurpean Union/United Kingdom SitesAdaptive COVID-19 Treatment Trial in the EU & UK (ACTT/EU/UK : A Multicenter, Adaptive, Randomised Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults - Version for European Union/United Kingdom Sites - Adaptive COVID-19 Treatment Trial in the EU & UK (ACTT-EU/UK)

Medienart:

Klinische Studie

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

WHO International Clinical Trials Registry Platform - (2020) vom: 14. Dez. Zur Gesamtaufnahme - year:2020

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Influenza COVID-19 MedDRA version: 20.0Level: HLTClassification code 10022005Term: Influenza viral infectionsSystem Organ Class: 100000004862;Therapeutic area: Diseases [C] - Virus Diseases [C02]
Phase: Phase 3
Recruitment Status: Not yet recruiting
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 20-03-2020, Last updated: 2022-11-24

ICTRP ID:

EUCTR2020-001052-18-DK
010
20-0006
Version no. 6.0

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

CTG005757371